PRELP inhibits colorectal cancer progression by suppressing epithelial-mesenchymal transition and angiogenesis via the inactivation of the FGF1/PI3K/AKT pathway
Xiaoqing Li, Zhongxiang Jiang, Junfeng Li, Kun Yang, Jin He, Qianxi Deng, Shuman Xu, Zhihang Jiang, Fuqiang Liu, Zheng Jiang, Fuqiang Liu, Zheng Jiang, Zheng Jiang
Topics & Concepts
Epithelial–mesenchymal transitionPI3K/AKT/mTOR pathwayCancer researchAngiogenesisProtein kinase BColorectal cancerTransition (genetics)ApoptosisCancerMedicineChemistryBiologyInternal medicineSignal transductionCell biologyMetastasisGeneBiochemistryFibroblast Growth Factor ResearchKruppel-like factors researchLipid metabolism and disorders